Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 14, 2026 · 10-Q · 44 days after period end · 0001493152-26-023163
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$765.99K | -$1.02M | -$865.97K | -$3.71M |
| EPS Diluted | -$0.43 | -$1.92 | -$1.31 | -$55.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end
